英文名稱 |
中文名稱 |
CAS號 |
操作 |
ODN 1826 |
ODN 1826 |
202668-42-6 |
詳細
|
Topoisomerase I inhibitor 8 |
化合物 TOPOISOMERASE I INHIBITOR 8 |
210346-40-0 |
詳細
|
2-(N-(2,6-Difluoropyridin-4-yl)cyanamido)-5-methyl-N-(spiro[3.4]octan-1-yl)thiazole-4-carboxamide |
|
2431970-42-0 |
詳細
|
ERD-12310A |
|
|
詳細
|
Gliocidin |
|
|
詳細
|
Ziresovir |
ZIRESOVIR |
1422500-60-4 |
詳細
|
Difluoromethylornithine |
消旋型二氟甲基腈鹽酸鹽 |
70052-12-9 |
詳細
|
3-Deazaneplanocin |
3-脫氮胸腺素A |
102052-95-9 |
詳細
|
CB-6644 |
CB-6644 |
2316817-88-4 |
詳細
|
Capzimin |
化合物 T10672 |
2084868-04-0 |
詳細
|
JNJ-28583113 |
2-(3-(4-(三氟甲基)苯基)-5,6,7,8-四氫環(huán)庚烷并[C]吡唑-1(4H)-基)乙酸乙酯 |
2765255-93-2 |
詳細
|
OGT2115 |
2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleaceticacid |
853929-59-6 |
詳細
|
Pentamidine |
噴他脒 |
100-33-4 |
詳細
|
Lupichromone |
Eriosemation |
162616-72-0 |
詳細
|
1α-Hydroxy-3-epi-vitamin D3 |
|
58028-00-5 |
詳細
|
SIRT5 inhibitor 7 |
化合物 SIRT5 INHIBITOR 7 |
2951090-00-7 |
詳細
|
IWY357/NVP-IWY357 |
IWY357 |
3052672-51-9 |
詳細
|
BMS-986397 |
|
2564486-44-6 |
詳細
|
TYRA-300 |
|
2800223-30-5 |
詳細
|
GS-1156(Elunonavir) |
|
2242428-57-3 |
詳細
|
NVP-DFF332 |
|
|
詳細
|
CHF-6523 |
|
2500579-21-3 |
詳細
|
BAY-2413555 |
|
2206665-50-9 |
詳細
|
NVP-EVS459 |
|
|
詳細
|
BAY2925976 |
|
2642235-06-9 |
詳細
|
WSF1-IN-1 |
WSF1-IN-1 |
2379577-82-7 |
詳細
|
2228847-12-7 |
|
2228847-12-7 |
詳細
|
SMAP-2 |
化合物 T12934 |
1809068-70-9 |
詳細
|
VX-166 |
|
800408-39-3 |
詳細
|
RXP03 |
|
284667-65-8 |
詳細
|
MS8790 |
|
3060730-06-2 |
詳細
|
AN-3485 |
AN-3485 |
1213827-99-6 |
詳細
|
N-(2-(2-((6-Chlorohexyl)oxy)ethoxy)ethyl)-3,6-bis(dimethylamino)-2'-(N,N-dimethylsulfamoyl)-10,10-dimethyl-3'-oxo-10H-spiro[anthracene-9,1'-isoindoline]-6'-carboxamide |
|
2434651-58-6 |
詳細
|
XIAP antagonist 1 |
|
375835-04-4 |
詳細
|
Iopromide Impurity 31 |
|
872117-56-1 |
詳細
|
Apicularen A |
apicularen A |
220757-04-0 |
詳細
|
STING agonist-32 |
|
2591300-74-0 |
詳細
|
BGT1-IN-9 |
2-amino-1,4,5,6-tetrahydropyrimidine-5-carboxylic acid hydrochloride |
185444-92-2 |
詳細
|
(S)-IDO1-IN-5 |
(S)-IDO1-IN-5 |
2166616-76-6 |
詳細
|
DKFZ-251 |
化合物 DKFZ-251 |
2222059-70-1 |
詳細
|
Rocaglaol |
洛克米蘭醇 |
147059-46-9 |
詳細
|
Lepadin H |
化合物 LEPADIN H |
412328-25-7 |
詳細
|
N-(3-Oxoundecanoyl)-L-homoserine lactone |
|
216596-70-2 |
詳細
|
TDP-43-IN-2 |
|
3033951-93-5 |
詳細
|
BMD4503-2 |
化合物 BMD4503-2 |
301357-87-9 |
詳細
|
Asulacrine free base |
化合物 ASULACRINE FREE BASE |
80841-47-0 |
詳細
|
Ulevostinag/MK-1454 |
|
2231258-61-8 |
詳細
|
2641821-68-1 |
|
2641821-68-1 |
詳細
|
2764998-32-3 |
|
2764998-32-3 |
詳細
|
2764998-33-4 |
|
2764998-33-4 |
詳細
|
P62-mediated mitophagy inducer |
P62-MEDIATED MITOPHAGY INDUCER |
1809031-84-2 |
詳細
|
N-[(4S)-1-Acetyl-1,2,3,4-tetrahydro-4-methyl-4-phenyl-6-quinolinyl]-3-(trifluoromethyl)benzenepropanamide |
(S)-N-(1-乙?;?4-甲基-4-苯基-1,2,3,4-四氫喹啉-6-基)-3-(3-(三氟甲基)苯基)丙酰胺 |
1421683-12-6 |
詳細
|
LU-002i |
化合物 LU-002I |
1838705-22-8 |
詳細
|
Proteasome β2c/i-IN-1 |
化合物 PROTEASOME Β2C/I-IN-1 |
2322333-75-3 |
詳細
|
STAT3 inhibitor C188 |
STAT3 Inhibitor IX, Cpd188 - CAS 823828-18-8 - Calbiochem |
823828-18-8 |
詳細
|
Mrgx2 antagonist-2 |
|
2767111-67-9 |
詳細
|
3932-44-3 |
|
3932-44-3 |
詳細
|
Biotinyl-NH-PEG3-C3-amido-C3-COOH |
|
1202761-21-4 |
詳細
|
VRK-IN-1 |
VRK-IN-1 |
2378855-09-3 |
詳細
|
(E)-3-Methyl-5-(phosphonooxy)pent-2-enoic acid |
|
2271369-82-3 |
詳細
|
RTC13 |
RTC13 |
1359825-94-7 |
詳細
|
Luffariellolide |
LUFFARIELLOLIDE |
111149-87-2 |
詳細
|
Cbl-b-IN-27 |
|
|
詳細
|
BLI-489 |
(5R,6Z)-6-[(5,6-Dihydro-8H-iMidazo[2,1-c][1,4]oxazin-2-yl)Methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid SodiuM Salt Hydrate |
623564-40-9 |
詳細
|
CP-346086 dihydrate |
CP 346086 Dihydrate |
186390-48-7 |
詳細
|
STING agonist-16 |
STING AGONIST 1A |
652142-94-4 |
詳細
|
MLS0315771 |
MLS0315771 |
727664-91-7 |
詳細
|
AZD7687 |
[反式-4-[4-(6-氨基甲酰基-3,5-二甲基吡嗪-2-基)苯基]環(huán)己基]乙酸 |
1166827-44-6 |
詳細
|
MC-Val-Cit-PAB-clindamycin |
MC-VAL-CIT-PAB-CLINDAMYCIN |
1639793-13-7 |
詳細
|
eIF4A3-IN-9 |
化合物 EIF4A3-IN-9 |
1402931-71-8 |
詳細
|
DMP 777 |
DMP 777 |
157341-41-8 |
詳細
|
IDX184 |
2'-C-甲基鳥苷 5'-[2-[(3-羥基-2,2-二甲基-1-氧代丙基)硫基]乙基 N-(苯基甲基)氨基磷酸酯] |
1036915-08-8 |
詳細
|
Cot inhibitor 1 |
8-C氯-4-[(3-氯-4-氟苯基)氨基]-6-[[[1-[2-(六氫-1H-氮雜-1-基)乙基]-1H-1,2,3-三唑-4-基]甲基]氨基]-3-喹啉甲腈 |
915365-57-0 |
詳細
|
BIIB-129 |
N-甲基-N-(順式-3-甲基-3-((6-(1-甲基-1H-吡唑-4-基)吡唑并[1,5-A]吡嗪-4-基)氧基)環(huán)丁基)丙烯酰胺 |
2770960-52-4 |
詳細
|
STING antagonist 1 |
|
3036981-21-9 |
詳細
|
L-Moses/L-45 |
2079885-05-3 |
2079885-05-3 |
詳細
|
Pirarubicin HCl |
吡柔比星鹽酸鹽 |
95343-20-7 |
詳細
|
2,2-Dimethyl-thiomorpholin-3-one |
3-巰基嗎啉酮,2,2-二甲基- |
50847-92-2 |
詳細
|
Glycine, N-[N-[N-[N-[N-[N-[(1,1-dimethylethoxy)carbonyl]glycyl]glycyl]glycyl]glycyl]glycyl]- (9CI) |
|
155521-05-4 |
詳細
|
2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethyl 4-methylbenzenesulfonate |
|
2889433-07-0 |
詳細
|
VX993 |
|
2877755-11-6 |
詳細
|
2-Chloro-6-methoxy-3-quinolinecarboxaldehyde |
2-氯-6-甲氧基喹啉-3-甲醛 |
73568-29-3 |
詳細
|
N-Cyclopentyl-2-((1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(3-phenylureido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl)acetamide |
|
2986044-04-4 |
詳細
|
Indomethacin formaldehyde (impurity) |
吲哚美辛-甲醛(雜質(zhì)) |
23694-51-1 |
詳細
|
ZK53 |
N-(4-溴芐基L)-4-(3,5-二氟芐基)哌嗪-1-甲酰胺 |
3031789-26-8 |
詳細
|
RJW100 |
化合物RJW100 |
1276664-20-0 |
詳細
|
LRH-1 modulator-1 |
化合物 LRH-1 MODULATOR-1 |
2244781-29-9 |
詳細
|
PC7A |
|
|
詳細
|